ORPHA:98912
Late-onset distal myopathy, Markesbery-Griggs type
Also known as: ZASP-related myofibrillar myopathy
Publications
1,448
Trials
0
Interventional, condition-specific
Researchers
50
Distinct authors in sample
Gene link
LDB3
Strong
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, non-dystrophic myofibrillar disorder characterized by late-adult onset of distal and/or proximal limb muscle weakness with initial involvement of posterior lower leg muscles, medial gastrocnemius and soleus. Patients present with ankle weakness followed by weakness of finger and wrist extensors and later on of proximal muscles. Ambulation is usually preserved. Late-onset associated and/or has been reported in a minority of cases.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0012277
- MeSH:C563718
- OMIM:609452
- UMLS:C4721886
Additional Mondo synonyms (5)
LDB3 myofibrillar myopathy (disease) · LDB3-related myofibrillar myopathy · myofibrillar myopathy (disease) caused by mutation in LDB3 · myofibrillar myopathy type 4 · myopathy, myofibrillar, type 4
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Strong — LDB3
- LiteraturePresent
1,448 matched papers (1,022 in last 10 years) Source
- Phenotype characterisedPresent
33 HPO annotations (e.g. Intrinsic hand muscle atrophy; Progressive proximal muscle weakness; Fatigable weakness of distal limb muscles) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 4 for broader category distal myopathy
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (LDB3).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
33
Associated phenotypes · MONDO:0012277
- Intrinsic hand muscle atrophy
- Progressive proximal muscle weakness
- Fatigable weakness of distal limb muscles
- Abnormality of the cardiovascular system
- Leg muscle stiffness
Showing 5 of 33 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,448
1,448 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,448 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,022 in the last 10 years · low confidence
Phrase hits: 5 · MeSH hits: 1
Who's working on it?
50
Distinct author names in 6 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Ala U1 paper · 2011Papers in Europe PMC
- 02Arbustini E1 paper · 2018
Centre for Inherited Cardiovascular Diseases, IRCCS Foundation, University Hospital Policlinico San Matteo, Pavia, Italy.
Papers in Europe PMC - 03Bakoš M1 paper · 2024
Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia.
Papers in Europe PMC - 04Bianco A1 paper · 2018
Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Papers in Europe PMC - 05Bondue A1 paper · 2018
Department of Cardiology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Papers in Europe PMC - 06Bracco C1 paper · 2011Papers in Europe PMC
- 07Chen S1 paper · 2017
Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Papers in Europe PMC - 08Chen X1 paper · 2023
Department of Cardiology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Papers in Europe PMC - 09Chen Y1 paper · 2017
Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Papers in Europe PMC - 10Ciccarelli M1 paper · 2018
School of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 4 trials are registered for distal myopathy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
4 interventional trials matched distal myopathy, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: distal myopathy
4
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Late-onset distal myopathy, Markesbery-Griggs type — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Late-onset distal myopathy, Markesbery-Griggs type" OR "ZASP-related myofibrillar myopathy" OR "LDB3 myofibrillar myopathy (disease)" OR "LDB3-related myofibrillar myopathy" OR "myofibrillar myopathy (disease) caused by mutation in LDB3" OR "myofibrillar myopathy type 4" OR "myopathy, myofibrillar, type 4") OR (MESH:"Myopathy, Myofibrillar, Zasp-Related") OR ("LDB3" OR "LDB3 syndrome" OR "LDB3-related")MeSH descriptor terms unioned into the query: Myopathy, Myofibrillar, Zasp-Related
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Late-onset distal myopathy, Markesbery-Griggs type" OR "ZASP-related myofibrillar myopathy" OR "LDB3 myofibrillar myopathy (disease)" OR "LDB3-related myofibrillar myopathy" OR "myofibrillar myopathy (disease) caused by mutation in LDB3" OR "myofibrillar myopathy type 4" OR "myopathy, myofibrillar, type 4" OR "Myopathy, Myofibrillar, Zasp-Related"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"distal myopathy"
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1448) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T05:42:51.048Z
